News | November 14, 2014

System named tops in five categories, including higher marks for pharmacy interfaces

 Elekta.Mosaiq

November 14, 2014 — According to a survey by KLAS, an independent research firm, Elekta's Mosaiq Oncology Information System earned the No. 1 ranking in the medical and/or radiology oncology category of KLAS' "Oncology 2014: Integration is Key" report. The survey of 247 customers of various vendors said that "Elekta has improved their Mosaiq interfaces to take a commanding lead over their competitors." Mosaiq scored 82.4 out of 100, 93 percent of customers said they would buy again and 96 percent confirmed that Mosaiq is part of their long-term plans.

This is the second year that it has received this recognition. It was also ranked highest in the KLAS' "Oncology 2013: Eyes Wide Open" report.

This year, the report indicated that in the "interface race," in which integration is more critical than functionality in the eyes of customers, providers were more pleased with Elekta's Mosaiq pharmacy interfaces than they were in the 2013 KLAS oncology report, achieving a rating of 8.0, eclipsing last year's mark of 7.1. "Elekta's single database for radiation and medical oncology continues to be a strength for the continuity of oncology care," the report states.

The survey also revealed high customer appreciation for the improved workflow automation that Elekta provides in Mosaiq via IQ Scripts, which "has been immensely helpful in speeding up workflow."

In the report, Mosaiq was the highest performer in five out of eight categories, covering both medical and radiation oncology.

Mosaiq is a complete patient information management system that efficiently manages patient care on a single solution, allowing effective treatment evaluation before, during and after delivery to ensure accuracy and safety. With more than 25 years of open systems support, Mosaiq connects seamlessly to virtually any linear accelerator and planning system from any vendor, giving centers the flexibility to choose solutions that perform optimally for their practice and patients.

For more information: www.elekta.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Artificial Intelligence

July 11, 2024 — Artificial Intelligence (AI) tools can play a key role in medical imaging if radiologists trust in their ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Therapy

June 19, 2024 — RaySearch Laboratories AB announced a milestone in radiotherapy technology where RaySearch’s RayStation ...

Time June 19, 2024
arrow
Subscribe Now